Carbilev side effects, by duration, gender and age (a phase IV clinical study of FDA data)

Summary:

Side effects are reported by people who take Carbilev (carbidopa; levodopa). Common side effects include death among females and death among males.

The phase IV clinical study is created by eHealthMe based on 61 reports from the FDA, and is updated regularly.

What is Carbilev?

Carbilev has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 102 Carbilev users. Check the latest studies of Carbilev.



On Jun, 26, 2026

61 people who take Carbilev and have side effects are studied.

Carbilev side effects.

What are the common side effects of Carbilev, by gender? *:

female:

  1. Death
  2. Hip arthroplasty
  3. Colitis (inflammation of colon)
  4. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  5. Pneumonia
  6. Respiratory disorder (respiratory disease)
  7. Blindness
  8. Blood count abnormal
  9. Cardiac failure
  10. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)

male:

  1. Death
  2. Gambling
  3. Drug intolerance (drug sensitivity)
  4. Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule)
  5. Kidney infection
  6. Malignant neoplasm progression (cancer tumour came back)
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Oedema peripheral (superficial swelling)
  9. On and off phenomenon
  10. Angina pectoris (chest pain due to ischemia of the heart muscle)

What are the common side effects of Carbilev, by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)

30-39:

n/a

40-49:

  1. Drug abuse

50-59:

  1. Gambling
  2. Hip arthroplasty
  3. Pathological gambling

60+:

  1. Death
  2. Angina pectoris (chest pain due to ischemia of the heart muscle)
  3. Gambling
  4. Hypersexuality
  5. Atrophy (wasting away of a part of the body)
  6. Blindness
  7. Blood count abnormal
  8. Cardiac failure
  9. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  10. Colitis (inflammation of colon)

What are the common side effects of Carbilev, by the time people have been on the drug (< 1 month to 10+ years)? *:

< 1 month:

  1. Pneumonia

1 - 6 months:

  1. Death

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Abasia (inability to walk)
  2. Atrophy (wasting away of a part of the body)
  3. Blindness
  4. Blood count abnormal
  5. Cardiac failure
  6. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  7. Delirium (wild excitement)
  8. Delusion (a false belief or opinion)
  9. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
  10. Drug abuse

* Approximation only. Some reports may have incomplete information.

Do you take Carbilev?

- Personalize this study to your gender and age
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



How the study uses the data?

The study is based on carbidopa; levodopa (the active ingredients of Carbilev) and Carbilev (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies are listed below in case you need more information:

Alternative drugs to, pros and cons of Carbilev:

All Carbilev side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: